Evaluation of the Efficacy of Imidacloprid 10%/Moxidectin 2.5% (Advocate®, Advantage® Multi, Bayer) for the Prevention of Dirofilaria repens Infection in Dogs

Empresa

Elanco

Data de Publicação

07/04/2022

PDF